When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer

Clin Adv Hematol Oncol. 2016 Jan;14(1):26-9.
No abstract available

Publication types

  • Interview

MeSH terms

  • Biomarkers, Tumor
  • Bone Neoplasms / secondary
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Male
  • Neoplasm Metastasis
  • Patient Selection
  • Practice Guidelines as Topic
  • Prognosis
  • Prostatic Neoplasms, Castration-Resistant / mortality
  • Prostatic Neoplasms, Castration-Resistant / pathology*
  • Prostatic Neoplasms, Castration-Resistant / radiotherapy*
  • Radioisotopes / therapeutic use*
  • Radium*
  • Time-to-Treatment*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Radioisotopes
  • Radium